This Robot Will Draw Your Blood Now
This Robot Will Draw Your Blood Now
Aletta, the first autonomous blood-draw device approved for use in the U.S., uses imaging and robotics to perform blood draws with high success rates, even in challenging cases. While it addresses staffing shortages in clinical labs, concerns about skin tone bias and sample quality persist, requiring further validation.
Aletta, the first autonomous blood-draw device authorized in the U.S., combines imaging and robotics to perform blood draws with high success rates, though concerns about skin tone bias and sample quality remain. The device addresses staffing shortages in clinical labs but requires further validation to ensure equitable performance across all demographics.
Evidence and limits
Published automatically after robotics and source-evidence checks; no manual editorial approval is recorded. Source assertions are not independently verified. Missing information remains not reported.
| Metric | Value / unit | Basis / context | Evidence |
|---|---|---|---|
| success rate | 94.5 percent | Reported trials Source wording: “Aletta successfully drew blood on the first attempt in 94.5 percent of cases” | Source E1 |
| complications | 0 percent | Basis not reported Source wording: “Complications were minimal, with multiple built-in safeguards to detect problems” | Source E1 |
| number of patients | 1,600 robots | Reported trials Source wording: “In a clinical trial involving more than 1,600 people in the Netherlands” | Source E1 |
| turnover rate | 25 percent | Basis not reported Source wording: “a median annual turnover rate of nearly 25 percent” | Source E1 |
| vacancy rate | 10 percent | Basis not reported Source wording: “a vacancy rate of close to 10 percent” | Source E1 |
- dataset: Not reported
Source excerpts and review record
No manual editorial approval recorded.
Original source quotation: “Aletta successfully drew blood on the first attempt in 94.5 percent of cases”
Source E1
Source：IEEE Spectrum — Robotics · spectrum.ieee.org